Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00222898 · ClinicalTrials.gov registry record
Cancer Detection in Pancreatic Cysts
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 300
- Enrollment target
NCT00222898: Completed study, sponsored by University of Pittsburgh.
NCT00222898 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 300 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00222898 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 300 participants
- Enrollment target
Study Summary
The purpose of this study is to assist with early and accurate diagnosis of cancer in pancreatic cysts based on the analysis of DNA obtained by endoscopic ultrasound guided fine needle aspiration
Interventions
- PROCEDURE DNA analysis of pancreatic cyst fluid / buccal swab
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2004-06 |
What the finished NCT00222898 record still lists
NCT00222898 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which DNA analysis of pancreatic cyst fluid / buccal swab is the first listed.
NCT00222898 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00222898 about?
NCT00222898 is a clinical study titled "Cancer Detection in Pancreatic Cysts". The purpose of this study is to assist with early and accurate diagnosis of cancer in pancreatic cysts based on the analysis of DNA obtained by endoscopic ultrasound guided fine needle aspiration
What is the current status of trial NCT00222898?
This trial is currently completed. The enrollment target is 300 participants. The study started on 2004-06.
What interventions are being tested in trial NCT00222898?
The interventions under investigation include: DNA analysis of pancreatic cyst fluid / buccal swab (PROCEDURE).
Who is sponsoring clinical trial NCT00222898?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia